Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The aim is to analyze the feasibility and effect of an online Therapeutic Exercise and Education programme (TEEP) in cancer patient and survivors
Description: Patients are asked before each session to mark in a numerical scale how are they feeling that day to push themselves and get their session well done. From 0 (very well) to 10 (very badly). Higher scores mean a worse feeling.
Measure: Suitability of exercise intensity Time: Through study completion, an average of 3 monthsDescription: Patients are asked to score the feeling of perceived effort after the session with the Borg Perceived Exertion scale (6-20). Higher scores mean a worse perceived exertion.
Measure: Verification of exercise intensity Time: Through study completion, an average of 3 monthsDescription: Total of days of attendance
Measure: Total attendance Time: After intervention, an average of 3 monthsDescription: Reasons of absence, categorized as: personal matter, visit the oncology, medical appointment (no related to oncology treatment), health problem, connection problem or unknown.
Measure: Absence type Time: Through study completion, an average of 3 monthsDescription: Attendance type, categorized as: full attendance, partly attendance because of lack of time, partly attendance because of internet connection problem
Measure: Attendance type Time: Through study completion, an average of 3 monthsDescription: The Spanish version of the Piper Fatigue Scale-Revised (PFS-R) will be used. Its total score is the sum of all items (from 0 to 220), with higher values indicate a higher level of fatigue (worse outcome)
Measure: Change from Cancer-Related Fatigue (CRF) Time: Prior and after intervention, an average of 3 monthsDescription: It will be tested by 30-second Sit-To-Stand Test (30-STS), number of repetitions completed.
Measure: Change from Functional capacity Time: prior and after intervention, an average of 3 monthsDescription: the Spanish version of Upper Limb Functional Index (ULFI) questionnaire will be filled online
Measure: Change from Upper limb functionality (%) Time: prior and after intervention, an average of 3 monthsDescription: the Spanish version of Lower Limb Functional Index (LLFI) questionnaire will be filled online
Measure: Change from Lower limb functionality (%) Time: prior and after intervention, an average of 3 monthsDescription: It will be assessed by The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) version 3.0. EORTC QLQ-C30 comprises 30 items and contains five functional scales, three symptom scales, a global health status/QoL scale, and six single items. Raw scores can be linearly converted to a 0-100 scale with higher scores reflecting higher levels of function (better outcome) and higher levels of symptom show bigger problems (worse outcome).
Measure: Change from Quality of life (self-reported questionnaire) Time: prior and after intervention, an average of 3 monthsDescription: It will be assessed by The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life questionnaire (EORTC QLQ-BR23). This is a breast cancer module of EORTC QLQ-C30 which contains 23 items that assess disease symptom, side effects of treatment, body image, sexual functioning, and future perspective. All items are rated on a 4-point scale (from 1- not at all, to very much). Higher scores represent better functioning (better outcome), and higher scores of symptom show bigger issues (worse outcome)
Measure: Change from specific Breast Cancer Quality of life (self-reported questionnaire) Time: prior and after intervention, an average of 3 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports